The myocardial protective effect of monosodium phosphate cardioplegia in cardiopulmonary bypass in infants with an atrial septal defect.

Szczegóły
Abstrakt

Tytuł:: The myocardial protective effect of monosodium phosphate cardioplegia in cardiopulmonary bypass in infants with an atrial septal defect.
Autorzy:: Yang F; Department of Cardiothoracic Surgery, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, China.
Wang J
Zhai B
Źródło:: Medicine [Medicine (Baltimore)] 2020 Jul 10; Vol. 99 (28), pp. e20934.
Typ publikacji:: Journal Article; Observational Study
Język:: English
Imprint Name(s):: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
MeSH Terms:: Cardiopulmonary Bypass/*methods
Cardiotonic Agents/*pharmacology
Heart Arrest, Induced/*methods
Heart Septal Defects, Atrial/*surgery
Phosphocreatine/*pharmacology
Adenosine Diphosphate/metabolism ; Adenosine Triphosphate/metabolism ; Cardiotonic Agents/administration & dosage ; Case-Control Studies ; Child, Preschool ; Extracorporeal Circulation/methods ; Female ; Heart Arrest/chemically induced ; Heart Septal Defects, Atrial/diagnosis ; Heart Septal Defects, Atrial/drug therapy ; Humans ; Infant ; Male ; Myocardial Reperfusion Injury/prevention & control ; Myocardium/chemistry ; Myocardium/enzymology ; Organ Preservation/methods ; Phosphocreatine/administration & dosage ; Postoperative Period ; Potassium Chloride/administration & dosage ; Potassium Chloride/pharmacology ; Protective Agents/administration & dosage ; Recovery of Function/drug effects
References:: Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H223-32. (PMID: 19395548)
Fetal Pediatr Pathol. 2014 Apr;33(2):92-7. (PMID: 24328941)
Kyobu Geka. 2012 Jan;65(1):58-62. (PMID: 22442860)
Expert Rev Cardiovasc Ther. 2015 Jan;13(1):85-94. (PMID: 25479322)
J Pak Med Assoc. 2013 May;63(5):662-5. (PMID: 23758007)
PLoS One. 2018 Mar 14;13(3):e0193845. (PMID: 29538428)
Cardiol Young. 2016 Jan;26(1):90-9. (PMID: 25599873)
Clin Sci (Lond). 2015 Jun;128(11):751-60. (PMID: 25599194)
Part Fibre Toxicol. 2014 Dec 09;11:63. (PMID: 25487314)
Asian Pac J Trop Med. 2016 Mar;9(3):269-73. (PMID: 26972400)
BMC Anesthesiol. 2014 Sep 18;14:78. (PMID: 25258591)
Mol Biol Cell. 2015 Mar 15;26(6):1188-98. (PMID: 25609085)
Crit Care. 2014 Nov 08;18(6):605. (PMID: 25490117)
Pediatr Cardiol. 2015 Jun;36(5):970-8. (PMID: 25605038)
Substance Nomenclature:: 0 (Cardiotonic Agents)
0 (Protective Agents)
020IUV4N33 (Phosphocreatine)
61D2G4IYVH (Adenosine Diphosphate)
660YQ98I10 (Potassium Chloride)
8L70Q75FXE (Adenosine Triphosphate)
Entry Date(s):: Date Created: 20200716 Date Completed: 20200727 Latest Revision: 20221005
Update Code:: 20240105
PubMed Central ID:: PMC7360231
DOI:: 10.1097/MD.0000000000020934
PMID:: 32664090
: Czasopismo naukowe

Full Text Finder

This study aimed to investigate the myocardial protective effect of liquid sodium phosphocreatine cardiac arrest in extracorporeal circulation surgery treating infants with atrial septal defects.Eighty-four infants with atrial septal defects who required extracorporeal circulation surgery treatment at our hospital from January 2016 to June 2018 were divided into an observation group and a control group through a digitally randomized method, with 42 cases in each group. The control group adopted the conventional modified St Thomas II high potassium cold liquid crystal cardiac arrest, while the observation group adopted the liquid sodium phosphocreatine cardiac arrest.The myocardial enzyme indexes of the 2 groups 3, 6, 12, and 24 hours postoperatively were higher than before establishing the cardiopulmonary bypass and the enzyme indexes of the control group at the same time were higher than that of the observation group; adenosine triphosphate, adenosine diphosphate, and other energy levels and the postoperative recovery rate energy levels of the observation group were higher than those in the control group, the difference was statistically significant (P < .05).Liquid sodium phosphocreatine cardiac arrest used in extracorporeal circulation surgery treating infants with atrial septal defects can reduce myocardial ischemia-reperfusion injury, maintain energy supply during ischemia, strengthen the St Thomas II effect, and aid postoperative cardiac function recovery of high potassium cold liquid crystal cardiac arrest used in infants with atrial septal defects and treated with extracorporeal circulation surgery.

Informacja